ERBB2 and gastric cancer: Using a combination of high-throughput virtual screening and in vitro analysis, we found that compound C3 from the ChemBridge small molecule library is a lead candidate that selectively targets EGFR and HER2 to stop cell growth in cell culture models of gastric cancer.